Search Results

1726 - 1750 of 75809
TitleWireDateTime
Saviynt Strengthens Executive Team to Accelerate AI Identity Security Leadership Globe Newswire 05/12 09:50
99% of High Point University Graduates Continue to Be Employed or Furthering Their Education Within 180 Days of Graduation Globe Newswire 05/12 09:49
Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress Globe Newswire 05/12 09:40
Vereigen Media Announces 'London Marketers Connect' An Exclusive B2B Marketing Gathering on the Thames, June 2026 Globe Newswire 05/12 09:38
Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease Globe Newswire 05/12 09:31
First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026  Globe Newswire 05/12 09:31
[Latest] Industrial Lubricant Market Size Will Attain USD 102.90 Billion by 2034 Growing at 5.80% CAGR - Exclusive Report by Zion Market Research Globe Newswire 05/12 09:30
Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting Globe Newswire 05/12 09:30
Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026 Globe Newswire 05/12 09:30
Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress Globe Newswire 05/12 09:30
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress Globe Newswire 05/12 09:30
South Street Securities Holdings Inc. Acquires 100% Equity Interest in Lime Funding LLC, an Asset-Backed Commercial Paper Conduit Globe Newswire 05/12 09:30
BlossomHill Therapeutics to Present Initial Clinical Dose Escalation Data from the Phase 1/1b Trial of BH-30236 in Patients with R/R AML or HR-MDS at EHA2026 Globe Newswire 05/12 09:30
Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias Globe Newswire 05/12 09:30
Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress Globe Newswire 05/12 09:30
21shares Launches THYP and TXXH, the First U.S. ETFs Tracking Hyperliquid Globe Newswire 05/12 09:30
Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress Globe Newswire 05/12 09:30
Ammonia Market worth $102.74 billion by 2031, at 3.71%, says MarketsandMarkets™ Globe Newswire 05/12 09:30
Star Bulk Announces Results of Its 2026 Annual Meeting of Shareholders Globe Newswire 05/12 09:30
Zodiac Partners II, LLC Launches a $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash Globe Newswire 05/12 09:29
OOH Delivers 2x the Performance Lift of TV, New OAAA and Kochava Study Finds Globe Newswire 05/12 09:26
PayZen Report: Healthcare Financial Pressures Mount as 73% of Systems Elevate Patient Payment Balances to a Top Priority Globe Newswire 05/12 09:15
LaFleur Expands Swanson Gold Deposit System, Confirming Strong Continuity with 2.95 g/t Au over 80.00 metres and 2.37 g/t Au over 88.05 metres Globe Newswire 05/12 09:15
Portnoy Law Firm Announces Class Action on Behalf of Gossamer Bio, Inc. Investors Globe Newswire 05/12 09:05
Portnoy Law Firm Announces Class Action on Behalf of Aldeyra Therapeutics, Inc. Investors Globe Newswire 05/12 09:05
1726 - 1750 of 75809

News, Photo and Web Search